gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Angiogenesis, Pathologic in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 5 (31.25) | 29.6817 |
2010's | 10 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, JS; Caruthers, SD; Hu, G; Lanza, GM; Schmieder, AH; Wickline, SA; Williams, TA; Winter, PM; Zhang, H | 1 |
Kiessling, F | 1 |
Brasch, RC; Chaopathomkul, B; Cyran, CC; Fu, Y; Rogut, V; Shames, DM; Wendland, MF | 1 |
Carme, S; Ceelen, W; De Naeyer, D; Debergh, I; Demetter, P; Pattyn, P; Robert, P; Smeets, P; Van Damme, N | 1 |
Berger, F; Lahrech, H; Nissou, MF; Perles-Barbacaru, AT; Sarraf, M; van der Sanden, B | 1 |
Haaga, J; Jin, E; Lu, ZR; Malamas, AS; Zhang, Q | 1 |
Jeong, EK; Kaneshiro, TL; Lu, ZR; Morrell, G; Parker, DL | 1 |
Barbier, EL; Beaumont, M; Farion, R; Lemasson, B; Rémy, C; Segebarth, C | 1 |
Bezy-Wendling, J; Kretowski, M; Mescam, M | 1 |
Barbier, EL; Bouchet, A; Coquery, N; Le Duc, G; Lemasson, B; Maisin, C; Rémy, C; Robert, P; Serduc, R; Troprès, I | 1 |
Blanckaert, P; Casneuf, V; Ceelen, WP; Delrue, LJ; Duyck, PC; Peeters, M; Van Damme, N | 1 |
Farion, R; Lahrech, H; Perles-Barbacaru, AT; van der Sanden, BP | 1 |
Allegrini, PR; Drevs, J; Esser, N; Fuxius, S; Hennig, J; Hugenschmidt, H; Konerding, MA; Marmé, D; Müller-Driver, R; Unger, C; Wittig, C; Wood, J | 1 |
Allegrini, PR; Baumann, D; Becquet, M; Brecht, K; Brueggen, J; Ferretti, S; McSheehy, PM; Rausch, M; Rudin, M; Schaeffer, F; Schnell, C; Wood, J | 1 |
Clement, O; Cuenod, CA; de Bazelaire, C; de Kerviler, E; Fournier, L; Frouin, F; Robert, P; Siauve, N | 1 |
Bléry, M; Contesso, G; Di Paola, R; Frouge, C; Guinebretière, JM | 1 |
16 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Angiogenesis, Pathologic
Article | Year |
---|---|
Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles.
Topics: Analysis of Variance; Animals; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Disease Progression; Gadolinium DTPA; Heterocyclic Compounds; Hindlimb; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Least-Squares Analysis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Neovascularization, Pathologic; Organometallic Compounds; Rabbits; Statistics, Nonparametric | 2013 |
Science to practice: will contrast agents for molecular imaging of angiogenesis help overcome the limitations of functional vascular imaging?
Topics: Contrast Media; Disease Progression; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Integrin alphaVbeta3; Magnetic Resonance Imaging; Molecular Imaging; Nanoparticles; Neovascularization, Pathologic; Organometallic Compounds | 2013 |
Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Capsules; Cell Line, Tumor; Contrast Media; Drug Monitoring; Heterocyclic Compounds; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Melanoma; Neovascularization, Pathologic; Organometallic Compounds; Polyethylene Glycols; Rats; Rats, Nude; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ 3 integrin.
Topics: Animals; Colorectal Neoplasms; Contrast Media; Coordination Complexes; Feasibility Studies; Heterocyclic Compounds; HT29 Cells; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Imaging; Molecular Probes; Muscle, Skeletal; Neovascularization, Pathologic; Organometallic Compounds; Peptides, Cyclic; Snake Venoms | 2014 |
Rapid-Steady-State-T1 signal modeling during contrast agent extravasation: toward tumor blood volume quantification without requiring the arterial input function.
Topics: Animals; Blood Volume; Blood Volume Determination; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Heterocyclic Compounds; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Models, Biological; Neovascularization, Pathologic; Organometallic Compounds; Rats; Rats, Inbred F344 | 2015 |
Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
Topics: Angiogenesis Inhibitors; Animals; Bumetanide; Capillary Permeability; Cell Line, Tumor; Colonic Neoplasms; Contrast Media; Cyclohexanes; DEET; Gadolinium DTPA; Heterocyclic Compounds; HT29 Cells; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Mice; Mice, Nude; Neovascularization, Pathologic; Organometallic Compounds | 2015 |
Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
Topics: Amides; Animals; Cell Line, Tumor; Chelating Agents; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Angiography; Mice; Mice, Nude; Molecular Conformation; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Organometallic Compounds | 2008 |
Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
Topics: Animals; Brain Neoplasms; Cell Membrane Permeability; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Glioma; Heterocyclic Compounds; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Microvessels; Neovascularization, Pathologic; Organometallic Compounds; Rats; Rats, Wistar | 2009 |
Multiscale model of liver DCE-MRI towards a better understanding of tumor complexity.
Topics: Algorithms; Capillary Permeability; Carcinoma, Hepatocellular; Computer Simulation; Contrast Media; Hepatic Veins; Heterocyclic Compounds; Humans; Image Interpretation, Computer-Assisted; Liver Circulation; Liver Neoplasms; Magnetic Resonance Imaging; Models, Biological; Neovascularization, Pathologic; Organometallic Compounds | 2010 |
Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media.
Topics: Analysis of Variance; Animals; Area Under Curve; Benzenesulfonates; Blood-Brain Barrier; Brain Neoplasms; Contrast Media; Disease Models, Animal; Glioma; Heterocyclic Compounds; Macromolecular Substances; Magnetic Resonance Imaging; Male; Neovascularization, Pathologic; Niacinamide; Organometallic Compounds; Phenylurea Compounds; Pyridines; Random Allocation; Rats; Sorafenib | 2010 |
Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.
Topics: Animals; Capillary Permeability; Cell Line, Tumor; Contrast Media; Heterocyclic Compounds; Image Enhancement; Magnetic Resonance Imaging; Male; Mice; Molecular Structure; Molecular Weight; Neovascularization, Pathologic; Organometallic Compounds; Pancreatic Neoplasms; Transplantation, Heterologous | 2011 |
How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging.
Topics: Animals; Blood Volume; Blood Volume Determination; Brain Mapping; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Glioma; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Microscopy, Fluorescence; Microvessels; Models, Anatomic; Neoplasm Transplantation; Neovascularization, Pathologic; Organometallic Compounds; Rats; Rats, Wistar | 2012 |
PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging.
Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Blood Vessels; Capillary Permeability; Carcinoma, Renal Cell; Enzyme Inhibitors; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorescent Dyes; Heterocyclic Compounds; Kidney Neoplasms; Magnetic Resonance Angiography; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Organometallic Compounds; Phthalazines; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow | 2002 |
PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Contrast Media; Female; Heterocyclic Compounds; Magnetic Resonance Imaging; Melanoma; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Organometallic Compounds; Phthalazines; Protein-Tyrosine Kinases; Pyridines; Vascular Endothelial Growth Factor A | 2005 |
Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma.
Topics: Algorithms; Animals; Computer Simulation; Contrast Media; Heterocyclic Compounds; Image Enhancement; Image Interpretation, Computer-Assisted; Indicator Dilution Techniques; Magnetic Resonance Imaging; Models, Cardiovascular; Neovascularization, Pathologic; Organometallic Compounds; Permeability; Rats; Rats, Wistar; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity | 2005 |
Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Contrast Media; Heterocyclic Compounds; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Neovascularization, Pathologic; Organometallic Compounds; Prospective Studies | 1994 |